Search research articles
Contact Us
Filters
Showing results (161-170 of 220) with videos related to
Page
of 22
Sort By:
The Journal of Infectious Diseases
|
August 4, 2007
Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients
Pablo Labarga, Vicente Soriano, Maria Eugenia Vispo, et al.
The Journal of Infection
|
April 2, 2013
Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response
Karin Neukam, Pablo Barreiro, Antonio Rivero-Juárez, et al.
HIV Clinical Trials
|
October 27, 2010
Simplification from protease inhibitors to once- or twice-daily raltegravir: the ODIS trial
Eugenia Vispo, Pablo Barreiro, Ivana Maida, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 12, 2013
Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin
Karin Neukam, Pablo Barreiro, Juan Macías, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 13, 2005
Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patients
Ana Lucía Rendón, Marina Núñez, Miriam Romero, et al.
Antiviral Therapy
|
September 14, 2010
Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy
Paula Tuma, Jose Medrano, Salvador Resino, et al.
AIDS Research and Human Retroviruses
|
September 23, 2006
Impact of antiretroviral treatment-related toxicities on hospital admissions in HIV-infected patients
María José Núñez, Luz Martín-Carbonero, Victoria Moreno, et al.
AIDS Research and Human Retroviruses
|
April 21, 2006
Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir
Teresa García-Benayas, Ana Lucía Rendón, Sonia Rodríguez-Novóa, et al.
HIV Clinical Trials
|
August 21, 2002
Salvage treatment with lopinavir/ritonavir (Kaletra) in HIV-infected patients failing all current antiretroviral drug families
Carmen de Mendoza, Luz Martín-Carbonero, Pablo Barreiro, et al.
AIDS Research and Human Retroviruses
|
May 30, 2008
Switch from ritonavir-boosted to unboosted atazanavir guided by therapeutic drug monitoring
Sonia Rodríguez-Nóvoa, Judit Morello, Pablo Barreiro, et al.
Page
of 22
Search research articles
Search
Showing results (161-170 of 220) with videos related to
Sort By:
Page
of 22
The Journal of Infectious Diseases
|
August 4, 2007
Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients
Pablo Labarga, Vicente Soriano, Maria Eugenia Vispo, et al.
The Journal of Infection
|
April 2, 2013
Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response
Karin Neukam, Pablo Barreiro, Antonio Rivero-Juárez, et al.
HIV Clinical Trials
|
October 27, 2010
Simplification from protease inhibitors to once- or twice-daily raltegravir: the ODIS trial
Eugenia Vispo, Pablo Barreiro, Ivana Maida, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 12, 2013
Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin
Karin Neukam, Pablo Barreiro, Juan Macías, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 13, 2005
Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patients
Ana Lucía Rendón, Marina Núñez, Miriam Romero, et al.
Antiviral Therapy
|
September 14, 2010
Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy
Paula Tuma, Jose Medrano, Salvador Resino, et al.
AIDS Research and Human Retroviruses
|
September 23, 2006
Impact of antiretroviral treatment-related toxicities on hospital admissions in HIV-infected patients
María José Núñez, Luz Martín-Carbonero, Victoria Moreno, et al.
AIDS Research and Human Retroviruses
|
April 21, 2006
Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir
Teresa García-Benayas, Ana Lucía Rendón, Sonia Rodríguez-Novóa, et al.
HIV Clinical Trials
|
August 21, 2002
Salvage treatment with lopinavir/ritonavir (Kaletra) in HIV-infected patients failing all current antiretroviral drug families
Carmen de Mendoza, Luz Martín-Carbonero, Pablo Barreiro, et al.
AIDS Research and Human Retroviruses
|
May 30, 2008
Switch from ritonavir-boosted to unboosted atazanavir guided by therapeutic drug monitoring
Sonia Rodríguez-Nóvoa, Judit Morello, Pablo Barreiro, et al.
Page
of 22